Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Amaxa launches high throughput nucleofection protocol

Amaxa launches high throughput nucleofection protocol

28th August 2007

Amaxa has launched a new nucleofection protocol with high throughput levels.

The company’s Shuttle protocol is suitable for nucleofection of SH-SY5Y and HepG2 cells, according to the manufacturer.

In this way, neurological studies and toxicological methods of replacing whole-animal testing could be improved.

"The new 96-well Shuttle nucleofection protocol allows high throughput approaches now to elucidate neurological functions," Amaxa states.

"HepG2 cells are often used for toxicological studies … high throughput approaches are now feasible by using the new 96-well Shuttle protocol."

The company adds that applications for neurological purposes include the ability to conduct studies which investigate the loss or gain of brain function.

Meanwhile, toxicological applications are centred on liver function in order to focus on the biochemistry of detoxification.

Kits available from Amaxa allow for up to ten 96-well reactions to be carried out and include the required number of nucleocuvette plates, supplement, transfecting agent pmaxGFP and nucleofector solution.ADNFCR-1050-ID-18258772-ADNFCR

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.